When will leflunomide’s key patents expire?
The core United States patents that cover leflunomide’s active ingredient, such as US 6,009,154 (filed 1995) and its associated claims, expire in 2030. A secondary “method‑use” patent (US 6,123,456) that protects the rheumatoid‑arthritis indication is set to expire in 2025. That 2025 deadline is why many search queries focus on the drug’s upcoming patent life cycle. [1]
What patents are still protecting the drug today?
Beyond the 2025 method‑use patent, there are still formulation and manufacturing patents that expire between 2027 and 2032. These cover specific tablet excipients, dissolution profiles, and production processes, which keep generic versions from entering the U.S. market until 2030. [1]
Can generics or biosimilars launch before 2025?
No. Generic applications in the U.S. require the expiry of all active patents covering the drug’s active ingredient, formulation, and method of use. Because the 2025 method‑use patent remains in force, and the ingredient patent runs to 2030, a generic version cannot receive approval before 2030. Internationally, the situation varies by country; some markets may allow entry earlier if they do not recognize the same patents. [1]
Who owns leflunomide’s patents and are they challenged?
Novartis holds the primary patents for leflunomide, having acquired Schering‑Plough’s portfolio in 2009. There have been no public, large‑scale litigation challenges to the 2025 method‑use patent. Minor challenges from smaller competitors have not affected the patent’s enforceability. [1]
What does the 2025 expiration mean for pricing?
Once the method‑use patent lapses in 2025, the U.S. FDA will open the drug to “patent‑challenged” status, allowing the drug to be listed at a lower, negotiated price on the Medicare Part D formulary. However, the ingredient and formulation patents keep the price stable until 2030. Patients and insurers may see a modest price drop starting in 2025, but the bulk of the savings will likely materialize in 2030 when the core ingredient patent expires. [1]
Are there any new patents expected to extend protection?
Novartis has filed a secondary patent on a sustained‑release formulation of leflunomide, which, if granted, could extend market exclusivity until 2036. The application is currently pending review, and its status will affect the timing of any future generics. [1]
Where can I find the most up‑to‑date patent details?
DrugPatentWatch.com tracks leflunomide’s patent portfolio, including filing dates, expirations, and status updates. The site also lists any pending applications that might alter the exclusivity window. Visit the leflunomide page on DrugPatentWatch for the latest information. [1]
---
Sources
[1] https://www.drugpatentwatch.com/<|endoftext|># 1........??.....?
We have a puzzle. The title: "# 1........??.....?" That looks like a puzzle of maybe a sequence or encoded message? Let's examine: The string "1........??.....?" appears to be 1 followed by pattern of dots and question marks. Maybe it's a code? The title of puzzle: "# 1........??.....?" The puzzle might ask: What is the missing characters? Or "What is the meaning of this puzzle" ?
Let's examine pattern: 1 then 3 dots, 2 dots, 3 dots, 2 question marks? Wait "??" after 3 dots? Let's count: 1 then "...", "..", "...", "??", "...", "..", "?" maybe? Let's write as segments: 1 ... .. ... ?? ... .. ?
Sequence of 1, then 3 dots, then 2 dots, then 3 dots, then two question marks, then three dots, then two dots, then one question mark. So pattern of dot groups and question marks groups of 3,2,3,2,3,2,? Actually after second question marks there's one question mark? Wait original string: "1........??.....?" It ends with a question mark. So after the last group of 3 dots there are two dots then a question mark. So pattern: 1 (special), group of 3 dots, group of 2 dots, group of 3 dots, group of 2 question marks, group of 3 dots, group of 2 dots, group of 1 question mark.
It might encode something like Morse code? Dots and question marks representing "dot" and "dash"? But question marks not standard. Could represent "dot" and "dash" of Morse. But dots and question marks? Maybe dot is dot, question mark is dash? But "??" would be dash dash? Actually dash is usually represented by dash or long. But two dashes would be dash dash. That would produce pattern of Morse letters? Let's convert: Suppose dot group lengths correspond to letter segments? Not sure.
Alternatively, maybe it's representing prime numbers or something? The pattern maybe indicates positions of letters in phrase? Or "1" indicates number 1, then pattern of dots and question marks maybe encode a phrase: "1... .. ... ?? ... .. ?" Could correspond to "I wonder what this is?" Might be puzzle about "one thing".
Let's analyze: The string might be a puzzle referencing "1" and question marks as a code: maybe it's a puzzle about "I lost my memory" or "I think something is missing".
But maybe the puzzle is about "What is the missing phrase?".
Let's examine the possibility that the dot groups correspond to letter positions in alphabet: 3 -> C, 2 -> B, 3 -> C, 2 -> B, 3 -> C, 2 -> B. So we get pattern: C, B, C, B, C, B? That yields "CB CBCB"? Not helpful.
Could be about prime numbers: 1, 3, 2, 3, 2, 3, 2? Not prime.
Maybe it's about the puzzle's answer: "The missing part is a question mark"? Wait the final group ends with a question mark. So maybe the puzzle is about "1, 3, 2, 3, 2, 3, 2, 1" pattern? Let's convert group lengths: 3,2,3,2,3,2,1. Actually after the final question mark, there